Lisdexamfetamine (Elvanse) is licensed in the UK for ADHD, not BED, and any use for BED would be off-label and is not routinely recommended by NICE
As a result, it caught the attention of researchers, local government leaders, and practitioners worldwide, with special attention paid to this in Europe
Struts catalog of tests is a little more targeted, with most being at least tangentially related to the companys other products
Long-acting agents, on the other hand, provide continuous receptor activation due to structural modifications that slow their absorption, reduce the rate of renal clearance or extend their half-lives [52, 53]
The compound is not yet approved as a pharmaceutical in Canada or the US, with FDA approval expected in 2026 to 2027
What is the difference between a sharps container and a regular pill bottle